ELAN

Elanco Animal Health Incorporated NYQ · ELAN

$25.43 +0.29 (+1.15%)

Neutral · +0.57σ

+ Compare Open in Sniper

Mkt cap $12.7B

P/E —

Day $25.05 – $25.82

52wk $19.40 – $27.72

Avg vol 5.8M

Beta 1.69

Div yld —

Next earnings 2026-08-05

Quick read

Plain English

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

ELAN last traded at $25.43, up 1.1% on the day; that's in the upper part of its 52-week range ($19.40–$27.72). Right now it's trading close to its recent average, with no strong stretch in either direction.

The next scheduled earnings report (2026-08-05) is the biggest known catalyst on the calendar, and day to day, watch whether it holds above or slips below its recent average.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

Today's read

Grading desk →

above KC1 lower, +0.52 ATR from EMA21 — no notable pattern

Long —

score 12 · tech 12 / 80 · support 0 / 20

above KC1 lower, +0.52 ATR from EMA21 · no notable pattern

· Chop regime — mean-reversion favored both ways

How this grade was earned

total 12 pts

Cycle position 6

Market fit 6

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

Short —

score 12 · tech 12 / 80 · support 0 / 20

below KC1 upper, +0.52 ATR from EMA21 · no notable pattern

· Chop regime — mean-reversion favored both ways

How this grade was earned

total 12 pts

Cycle position 6

Market fit 6

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $35.50 (fair range $16–$36); today's price leaves a +27% cushion below that estimate. The model's verdict is “Undervalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Intrinsic (DCF)

$35.50

Fair-value range

$15.55 – $35.50

Margin of safety

+27%

Verdict

Undervalued

Accounting quality Weak

✓ Current ratio 2.17 (antifragile)
✓ Gross margin 55% (pricing power)

⚠ Debt exceeds cash
⚠ Quick ratio 0.81 (fragile)
⚠ Negative retained earnings

Price implies ~11% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

ELAN is a $12.7 billion company, it moves harder than the market (beta 1.7).

Mkt cap $12.7B

P/E ttm —

Fwd P/E 21.3

Beta 1.69

Day range $25.05 – $25.82

52w range $19.40 – $27.72

Avg vol 5.8M

RSI(2) 49.0

ROE -3.8%

Net mgn -4.9%

FCF mgn 14.1%

Debt/Eq 0.66

Div yld —

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Next earn 2026-08-05

52-week range · today's price

$19.40$27.72

More on ELAN

Options idea

See more →

CALL $26 2026-08-21

$1.38

PUT $25 2026-08-21

$1.30

Earnings

See more →

Last reported: 2026-05-06
EPS (act / est): 0.40 / 0.34
Surprise: +16.6%
Next report: 2026-08-05

About

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescri…